Trial intelligence / Profile preview

Sodium Bicarb Locks in Intestinal Failure

NCT05813535Phase 2Completed

Start
Dec 2022
Primary completion
Mar 2025
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of sodium bicarbonate ringer's solution in catheter-related bloodstream infection (CRBSI). Primary endpoint: Rate of Catheter Related Bloodstream Infections at 1 year. Started Dec 2022; status: completed.

02

Drugs

sodium bicarbonate ringer's solution
03

Conditions

catheter-related bloodstream infection (CRBSI)

Beyond the preview

Go deeper on NCT05813535.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05813535.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call